当前位置:首页 - 行情中心 - 万孚生物(300482) - 财务分析 - 现金流量表

万孚生物

(300482)

  

流通市值:77.20亿  总市值:84.02亿
流通股本:4.30亿   总股本:4.68亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金586,603,192.812,455,407,503.831,752,258,544.331,134,980,629.79
  客户存款和同业存放款项净增加额--0-
  向中央银行借款净增加额--0-
  向其他金融机构拆入资金净增加额--0-
  收到原保险合同保费取得的现金--0-
  收到再保险业务现金净额--0-
  保户储金及投资款净增加额--0-
  收取利息、手续费及佣金的现金--0-
  拆入资金净增加额--0-
  回购业务资金净增加额--0-
  收到的税费返还4,716,434.5819,366,624.9511,320,256.152,906,654.65
  收到其他与经营活动有关的现金10,953,390.8436,360,754.1626,759,545.3516,577,305.5
  经营活动现金流入的其他项目--0-
  经营活动现金流入小计602,273,018.232,511,134,882.941,790,338,345.831,154,464,589.94
  购买商品、接受劳务支付的现金91,655,442.57617,224,111.5535,744,810.8368,579,617.19
  客户贷款及垫款净增加额--0-
  存放中央银行和同业款项净增加额--0-
  支付原保险合同赔付款项的现金--0-
  支付利息、手续费及佣金的现金--0-
  支付保单红利的现金--0-
  支付给职工以及为职工支付的现金173,172,391.59847,739,686.38687,094,266.64470,194,564.38
  支付的各项税费11,121,672.76124,949,520.95117,553,373104,803,315.71
  支付其他与经营活动有关的现金108,153,783.25458,184,003.26397,236,699.67267,198,543.92
  经营活动现金流出的其他项目--0-
  经营活动现金流出小计384,103,290.172,048,097,322.091,737,629,150.111,210,776,041.2
  经营活动产生的现金流量净额218,169,728.06463,037,560.8552,709,195.72-56,311,451.26
二、投资活动产生的现金流量:
  收回投资收到的现金1,588,523,888.784,611,416,456.033,577,903,506.112,543,601,533.85
  取得投资收益收到的现金18,912,385.0848,704,644.7735,447,154.7127,479,777.45
  处置固定资产、无形资产和其他长期资产收回的现金净额24,948.98453,801.0631,083.1131,083.11
  处置子公司及其他营业单位收到的现金净额-1,009,227.872,857,406.591,499,349.59
  收到的其他与投资活动有关的现金--0-
  投资活动现金流入小计1,607,461,222.844,661,584,129.733,616,239,150.522,572,611,744
  购建固定资产、无形资产和其他长期资产支付的现金36,358,438.76304,552,406.53205,887,567.42117,590,146.77
  投资支付的现金1,879,838,081.424,774,491,696.473,702,393,071.472,659,312,987.19
  质押贷款净增加额--0-
  取得子公司及其他营业单位支付的现金--0-
  支付其他与投资活动有关的现金--0-
  投资活动现金流出小计1,916,196,520.185,079,044,1033,908,280,638.892,776,903,133.96
  投资活动产生的现金流量净额-308,735,297.34-417,459,973.27-292,041,488.37-204,291,389.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金--0-
  其中:子公司吸收少数股东投资收到的现金--0-
  取得借款收到的现金--0-
  收到其他与筹资活动有关的现金653,096.587,046,953.464,736,302.253,134,503.78
  筹资活动现金流入小计653,096.587,046,953.464,736,302.253,134,503.78
  偿还债务支付的现金--0-
  分配股利、利润或偿付利息支付的现金-200,577,371.67205,920,844.32192,569,904.4
  其中:子公司支付给少数股东的股利、利润-2,940,0002,592,000-
  支付其他与筹资活动有关的现金0216,812,245.46184,874,983.2737,770,015.31
  筹资活动现金流出小计0417,389,617.13390,795,827.59230,339,919.71
  筹资活动产生的现金流量净额653,096.58-410,342,663.67-386,059,525.34-227,205,415.93
四、汇率变动对现金及现金等价物的影响-1,385,935.36-1,339,102.5-266,391.73635,699.82
五、现金及现金等价物净增加额-91,298,408.06-366,104,178.59-625,658,209.72-487,172,557.33
  加:期初现金及现金等价物余额461,998,850.06828,103,028.65828,103,028.65828,103,028.65
  期末现金及现金等价物余额370,700,442461,998,850.06202,444,818.93340,930,471.32
补充资料:
  净利润--69,658,473.46-190,209,871.9
  资产减值准备-24,661,464.55-6,179,297.87
  固定资产和投资性房地产折旧-222,596,633.58-106,893,827.42
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-222,596,633.58-106,893,827.42
  无形资产摊销-35,362,085.74-18,115,759.43
  长期待摊费用摊销-5,029,881.04-1,787,510.77
  处置固定资产、无形资产和其他长期资产的损失--318,789.99-2,089.9
  固定资产报废损失-4,988,270.15-2,275,023.46
  公允价值变动损失--13,639,950.87--17,604,203.48
  财务费用-25,640,854.92-15,249,638.48
  投资损失--39,786,048.52--9,519,032.06
  递延所得税--50,760,886.55--5,608,598.36
  其中:递延所得税资产减少--36,544,624.42-1,868,865.18
    递延所得税负债增加--14,216,262.13--7,477,463.54
  存货的减少-70,340,155.59-17,832,234.34
  经营性应收项目的减少-271,583,502.28--175,342,738.61
  经营性应付项目的增加--134,926,097.1--209,687,161.13
  其他-106,418,000-0
  融资租入固定资产-1,304,714.59--
  现金的期末余额-461,998,850.06-340,930,471.32
  减:现金的期初余额-828,103,028.65-828,103,028.65
  现金及现金等价物的净增加额--366,104,178.59--487,172,557.33
公告日期2026-04-232026-04-232025-10-272025-08-20
审计意见(境内)标准无保留意见
TOP↑